| Literature DB >> 33867927 |
Yousuke Tsuneoka1, Hiromasa Funato1,2.
Abstract
The preoptic area (POA) has long been recognized as a sleep center, first proposed by von Economo. The POA, especially the medial POA (MPOA), is also involved in the regulation of various innate functions such as sexual and parental behaviors. Consistent with its many roles, the MPOA is composed of subregions that are identified by different gene and protein expressions. This review addresses the current understanding of the molecular and cellular architecture of POA neurons in relation to sleep and reproductive behavior. Optogenetic and pharmacogenetic studies have revealed a diverse group of neurons within the POA that exhibit different neural activity patterns depending on vigilance states and whose activity can enhance or suppress wake, non-rapid eye movement (NREM) sleep, or rapid eye movement (REM) sleep. These sleep-regulating neurons are not restricted to the ventrolateral POA (VLPO) region but are widespread in the lateral MPOA and LPOA as well. Neurons expressing galanin also express gonadal steroid receptors and regulate motivational aspects of reproductive behaviors. Moxd1, a novel marker of sexually dimorphic nuclei (SDN), visualizes the SDN of the POA (SDN-POA). The role of the POA in sleep and other innate behaviors has been addressed separately; more integrated observation will be necessary to obtain physiologically relevant insight that penetrates the different dimensions of animal behavior.Entities:
Keywords: Moxd1; NREM sleep; REM sleep; galanin; male sexual behavior; parental behavior; preoptic area; sexual dimorphism
Year: 2021 PMID: 33867927 PMCID: PMC8044373 DOI: 10.3389/fnins.2021.649159
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
FIGURE 1Neuroanatomy and heterogeneity of the medial preoptic area. (A) Coronal mouse brain diagram showing the MPOA subregions at the level of the MPNc (bregma, –0.02 mm). (B) Double ISH for Penk (blue) and neurotensin (magenta) mRNAs with immunostaining for calbindin (green). (C) ISH for Vglut2 (green) mRNA with immunostaining for oxytocin (magenta). (D) Summary of marker genes expression in selected MPOA subregions. Each subregion has a characteristic pattern of marker expression. Scale bars: 100 μm. 3v, third ventricle; ac, anterior commissure; ACN, anterior commissural nucleus; BNSTdm, dorsomedial nucleus of the BNST; BNSTmg, magnocellular nucleus of the BNST; cMPOA, central part of the MPOA; dmMPOA, dorsomedial part of the MPOA; MPNc, central part of the MPN; MPNl, lateral part of the MPN; MPNmp, posteromedial part of the MPN; MPNvl, ventrolateral part of the MPN; opt, optic tract; PD, posterodorsal preoptic nucleus; vMPOA, ventral part of the MPOA; vlMPOA, ventrolateral part of the MPOA; VLPO, ventrolateral preoptic nucleus. Modified from Tsuneoka et al. (2017b).
FIGURE 2Galanin and neurotensin mRNA expression in the preoptic area. (A,B) Double ISH for (A) galanin and (B) neurotensin of a coronal section of the mouse brain (bregma + 0.10 mm). (C,D) Double ISH for (C) galanin and (D) neurotensin of a coronal section of the mouse brain (bregma –0.02 mm). (E,F) Double ISH for (E) galanin and (F) neurotensin of a coronal section of the mouse brain (bregma, –0.14 mm). (G,H) Double ISH for (G) galanin and (H) neurotensin of a coronal section of the mouse brain (bregma, –0.24 mm). Scale bars: 200 μm. 3v, third ventricle; ac, anterior commissure; ACN, anterior commissural nucleus; AH, anterior hypothalamus; BNST, bed nucleus of the stria terminalis; fx, fornix; LAN, lateroanterior hypothalamic nucleus LPOA, lateral preoptic area; MPOA, medial preoptic area; MPN, medial preoptic nucleus; NDB, nucleus of the diagonal band; opt, optic tract; PVPOA, periventricular preoptic area; SCN, suprachiasmatic nucleus; SI, substantia innominata; SON, supraoptic nucleus; VLPO, ventrolateral preoptic nucleus. Adapted from Tsuneoka et al. (2013).
Preoptic area neuron subtypes that regulate physiology and behavior.
| Marker | Localization1 | Manipulation | Results | References |
| Adcyap1 | VMPO | Activation | Decrease in body temperature | |
| BDNF | VMPO | Activation | Decrease in body temperature | |
| CCK | Lateral MPOA and LPOA | Activation | Increase in NREM and REM sleep | |
| Decrease in wakefulness | ||||
| Inhibition | Decrease in NREM and REM sleep | |||
| Increase in wakefulness | ||||
| CRH | Lateral MPOA and LPOA | Activation | Increase in NREM and REM sleep | |
| Decrease in wakefulness | ||||
| Inhibition | Decrease in NREM and REM sleep | |||
| Increase in wakefulness | ||||
| Esr1 | MPOA | Activation | Enhanced pup retrieval | |
| Activation | No change in maternal nest building | |||
| Activation | Enhanced male-type mounting of both males and females | |||
| Inhibition | Suppressed pup-directed behavior | |||
| Inhibition | Suppressed male mounting | |||
| Ablation | Suppressed pup retrieval | |||
| Ablation | Suppressed male mounting | |||
| GAD2 | Lateral MPOA and LPOA | Activation | Increase in wakefulness | |
| GAD2, projection | Lateral MPOA and LPOA | Activation | Increase in NREM and REM sleep | |
| to TMN | Decrease in wakefulness | |||
| Inhibition | Decrease in NREM and REM sleep | |||
| Increase in wakefulness | ||||
| Galanin | Lateral MPOA and LPOA | Activation | Increase in wakefulness | |
| Activation | Increase in NREM sleep | |||
| Increase in NERM sleep delta power | ||||
| Activation | Decrease in body temperature | |||
| Ablation | Fragmented sleep | |||
| Blunted response to sleep deprivation | ||||
| Ablation | Increase in body temperature | |||
| Lateral MPOA | Activation | Increased in NREM sleep | ||
| No change in REM sleep | ||||
| Increase in delta power during all states | ||||
| Activation | Decrease in body temperature | |||
| Inhibition | Increase in wakefulness | |||
| Decrease in NREM sleep | ||||
| No change in REM sleep | ||||
| Activation | Suppressed infanticide | |||
| Enhanced pup grooming | ||||
| Activation | No change in male sexual behavior | |||
| Ablation | Suppressed pup retrieval | |||
| Enhanced infanticide | ||||
| Ablation | Suppressed male sexual behavior | |||
| Galanin, projection | MPOA | Activation | Suppressed male infanticide | |
| to PAG | Enhanced pup grooming | |||
| Inhibition | Suppressed pup grooming | |||
| Galanin | MPOA | Activation | Enhanced motivation to interact with pups | |
| Projection to VTA | Inhibition | Suppressed motivation to interact with pups | ||
| Galanin, projection | MPOA | Activation | No change in pup-directed behavior | |
| to MeA | Enhanced male–male aggression | |||
| Inhibition | No change in pup-directed behavior | |||
| No change in male–male aggression | ||||
| Leptin receptor | VMPO | Activation | Decrease in body temperature | |
| Nos1 warm-sensitive | MnPO and MPOA | Activation | Increase in NREM sleep | |
| Activation | Decrease in body temperature | |||
| Opn5 | VMPO | Activation | Decrease in body temperature | |
| Inhibition | Increase in body temperature | |||
| Pdyn | Lateral MPOA and LPOA | Activation | Increase in NREM sleep | |
| Tac1 | Lateral MPOA and LPOA | Activation | Increase in NREM sleep | |
| Activation | Increase in wakefulness | |||
| Inhibition | Decrease in NREM and REM sleep | |||
| Inhibition | No change in wakefulness | |||
| Trpm2 | MPOA | Activation | Decrease in body temperature | |
| Inhibition | Increase in body temperature | |||
| Vgat | MnPO | Activation | Increase in NREM sleep | |
| Decrease in REM sleep | ||||
| No change in wakefulness | ||||
| Ablation | Increase in body temperature | |||
| Vgat | MnPO | Activation | No change in body temperature | |
| MPOA | Activation | Enhanced pup retrieval | ||
| Enhanced maternal nest building | ||||
| Activation | No change in body temperature | |||
| Inhibition | Suppressed maternal nest building | |||
| No change in pup retrieval | ||||
| VMPO | Activation | No change in body temperature | ||
| Vglut2 | Lateral MPOA and LPOA | Activation | Increase in wakefulness | |
| MPOA | Activation | Decrease in body temperature | ||
| MnPO | Activation | Decrease in body temperature | ||
| VMPO | Activation | Decrease in body temperature | ||
| VLPO | Activation | Increase in wakefulness | ||
| Decrease in NREM and REM sleep | ||||
| Vglut2, projection to PAG | Lateral MPOA and LPOA | Activation | Increase in wakefulness |
FIGURE 3Models of POA neuron groups that regulate sleep and reproductive behavior. (A) Different subgroups of POA GABAergic neurons control sleep and wakefulness differently. TMN-projecting GABAergic neurons promote NREM sleep and strongly REM sleep. Galanin-positive POA neurons that are mainly GABAergic generally promote NREM sleep. POA glutamatergic neurons promote wakefulness. (B) Estrogen receptor α and/or galanin-positive neurons in the MPOA regulate parental behavior and male sexual behavior. Neurons involving nest building behavior was not estrogen receptor α positive. BNST, bed nucleus of the stria terminalis; LPOA, lateral preoptic area; MeA, medial amygdala; MPOA, medial preoptic area; PAG, periaqueductal gray; TMN, tuberomammillary nucleus; VLPO, ventrolateral preoptic nucleus; VTA, ventral tegmental area.
FIGURE 4Moxd1 mRNA as a marker for sexually dimorphic nucleus. (A,B) Moxd1 mRNA expression in the sexually dimorphic nucleus of the POA (SDN-POA) of (A) male and (B) female mice. The number of Moxd1-positive cells of the SDN-POA are higher in males than in females. (C,D) The SDN-POA has cells expressing (C) Moxd1 and (D) calbindin. (E) Merged images of Moxd1 and Calbindin. (F,G) Moxd1, calbindin, merged image of dashed rectangles in panels (C–E). Scale bars: (A) 200 μm, (E) 100 μm, and (H) 50 μm. Modified from Tsuneoka et al. (2017a).